Agnirva Space Premier League - Expedition #30430: Fighting Space-Induced Bone Loss: How Sclerostin Antibodies May Transform Space Medicine

Spaceflight can do amazing things—but it can also pose serious risks to astronauts' health, especially their bones. In the microgravity environment of space, bones weaken and lose density at alarming rates. This NASA-sponsored study led by Dr. Chris Paszty and team explores an innovative solution: using a sclerostin antibody, a powerful bone-forming agent, to combat spaceflight-induced skeletal fragility. By examining how these antibodies affect mice aboard the International Space Station, researchers hope to identify new treatments for osteoporosis and bone loss both in space and here on Earth. With data collected from Expedition 27/28, this study pushes the frontiers of bone biology and offers hope for safer long-duration missions.

Join the Agnirva Space Internship Program to explore more groundbreaking research like this!

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.